2012 ASCO Annual Meeting Sunday

Chicago, IL - ASCO 2012 Annual Meeting: - Ranee Mehra presents First-in-human phase I study of the ALK inhibitor LDK378 in advanced solid tumors. during Developmental Therapeutics - Experimental Therapeutics at the American Society for Clinical Oncology (ASCO) Annual Meeting here today, Sunday June 3, 2012. Over 31,000 physicians, researchers and healthcare professionals from over 100 countries are attending the meeting which is being held at the McCormick Convention center and features the latest cancer research in the areas of basic and clinical science. Photo by © ASCO/Silas Crews 2012 Technical Questions: todd@toddbuchanan.com; ASCO Contact: photos@asco.org